Technical guidance on the Introduction of HPV vaccines in European Union countries – an update
In January 2008, a panel of ECDC experts produced the Guidance for the introduction of HPV vaccines in EU countries. Since then, the European Union has come a long way: most countries have implemented national vaccination programmes for adolescent girls and a significant number have also introduced catch-up programmes for young women.
Expert opinion on the Introduction of HPV Vaccines in EU Countries
This guidance report lays down the scientific basis for the potential introduction of human papillomavirus (HPV) vaccines in order to help EU Member States to make policy choices
Economic evaluation of human papilloma virus vaccination in the European Union: a critical reviewArchived
The authors performed a literature review of all economic evaluations (EEs) of HPV vaccines conducted in EU countries and published in English from January 2007 to June 2010. EEs were classified and compared according to their model, the economic variables used, the modelling techniques and whether or not they had financial backing from vaccine manufacturers.
Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based studyArchived
Similar to other European countries, cervical infection with HPV-16, the HPV type with the strongest oncogenic potential, were most common both overall and among women with cervical disease.
Detection of human papillomavirus DNA in urine. A review of the literatureArchived
HPV DNA detection in urine is a feasible practice and a useful tool in future research; however, the available studies dealing on the topic appear too diverse in their setup and applied methodology to draw conclusive statements
ECDC guidance on HPV vaccination: Focus on reaching all girlsArchived
Today, ECDC publishes an update to its 2008 Guidance on human papillomavirus (HPV) vaccines in Europe. The update follows the introduction of vaccination programmes in 19 European countries and new evidence from research studies over the past four years.